arXiv Science⌕ Search

arXiv subjects

Lingsen You

Publications and source records attributed to Lingsen You.

3 recordsLinked to original sources

ScienceBuddy-PV: A Verifier-Governed Recursive Improvement Protocol for Panvascular Intervention Research

ScienceBuddy-PV adapts the ScienceBuddy recursive-in-recursive design to panvascular intervention research through a structured evidence ledger, device-vessel ontology, abstention contract and retained failure bank. Recursive harness optimization and outer-loop model learning, including reinforcement learning, are specified but not executed. We audit a fixed component, rather than the complete agent system, using separate ARCADE syntax and stenosis tasks (1,000 training, 200 validation and 300 test images per task). A shared task-masked convolutional model was trained once per representation setting; its parameters and the heuristic support gate were then held fixed, with the stenosis threshold selected on validation data. On the locked test sets, syntax Dice was 0.475 (95% CI 0.459-0.490) and stenosis Dice was 0.231 (95% CI 0.214-0.249). Stenosis pixel AUROC was 0.957 and AUPRC was 0.180 at prevalence 0.00975. The gate accepted 76.7% of stenosis-frame outputs versus 100% for a score-only comparator. In a constructed mask audit, it accepted 44.3% of reference candidates and rejected 55.7%, exposing the cost of abstention. Acceptance does not establish correctness or clinical safety. This public-data component audit makes support and abstention measurable and provides a reproducible protocol for future collaborative agent studies. It does not demonstrate recursive improvement, patient-level validity or clinical device recommendations.

cs.AI↗

Intervention anchors and scientific verification in synthetic vascular predictive representations

Complete orthogonal predictive coordinates do not by themselves bind a latent direction to a named intervention. We present a mathematical and synthetic audit motivated by vascular device-vessel suitcordance. Capacity-matched least-squares predictors were exactly equivalent under complete fixed output transforms, whereas an anchor-only observer recovered interpretations only within the span of known perturbation signatures. Six three-dimensional configurations across 64 seeds gave a maximum paired prediction discrepancy of 6.7e-15 but a median untransported edit error of 1.513. Coordinate transport removed that error. Noisy and weak anchors constrained calibration stability, and changing the representation basis required recalibration or verified transport. Across 256 additional fits in dimensions 3-24, prediction equivalence persisted within 4.0e-15. We then evaluated nine deliberate runnable fault classes across 64 seeds. All 576 faulty executions completed, but each violated at least one reconstruction, prediction, delivered-edit or scope contract; all 320 valid control records passed. Repeating a faulty implementation gave exact self-agreement despite error against the separately computed simulator expectation. For one omitted-direction defect, probe coverage followed its analytic law, and rank-aware abstention protected unsupported interpretations. Scalar-noise experiments exposed both missed weak faults and excessive rejection under narrow relative tolerances. These controls provide an executable separation of prediction, semantic support and scientific acceptance. They are synthetic numerical audits, not clinical validation, neural JEPA-Anything replication, agent learning or patient treatment-effect estimation.

cs.AI↗

An immune world model for multiscale forecasting and therapeutic hypothesis generation

Immune therapies act across cell-intrinsic programs, tissue ecosystems, and patient-specific immune states, yet most predictors address these scales separately. We used a governed evolutionary AI Scientist to construct the Immune World Model, an action-conditioned model that learns how interventions move immune states across cellular, tissue, and individual levels. The Immune World Model--building Scientist searched candidate architectures and workflows, and the resulting world model was frozen before independent confirmation. The frozen model generalized to unseen interventions and biological contexts, recovered intervention-specific cellular programs, integrated cell and tissue information to improve ecosystem and patient-response prediction, and forecast unseen perturbation combinations. Immune World Model--guided analysis then combined measured perturbations with cross-axis inference to nominate IL-36$γ$ plus SIRP$α$ inhibition as a complementary-axis therapeutic hypothesis, whereas a governed self-correction audit rejected every screened cytokine pair. The Immune World Model provides a framework for multiscale immune simulation that connects AI Scientist-driven model construction, intervention forecasting, and the generation of prospectively testable therapeutic hypotheses.

cs.LG↗